TABLE 1.

Impact of CVD on patients with T2D

Factor	Prevalence	Risk factors	Economic impact	HRQoL
CVD (including CHD, cerebrovascular disease, peripheral arterial disease, or heart failure)	~70 per 1000 patients with diabetes (hospitalization discharge data) 2	Age, obesity, tobacco use, dyslipidaemia, hypertension 23	Increases annual treatment costs per patient by 112% (compared with patients with T2D and without CVD) 80	‐
CHD	~18 per 1000 patients with diabetes (hospitalization discharge data) 2	As above	Increases annual treatment costs per patient by 107% (compared with patients with T2D and without CHD) 80	Presence of angina reduced this from 0.82 to 0.17; presence of other CHD from 0.82 to 0.78 91
Stroke	~12 per 1000 patients with diabetes (hospitalization discharge data) 2	As above	Increases annual treatment costs per patient by 322% (compared with patients with T2D and without a stroke) 80	Presence of hemiplegia stroke reduced this from 0.82 to 0.68 91 ; transient ischaemic attack reduced this to 0.75; a cerebral vascular accident reduced this to 0.73 91
HF	~12 per 1000 patients with diabetes 92	As above	Increases annual treatment costs per patient by 59% (compared with patients with T2D and without HF) 80	Presence of HF reduced this from 0.82 to 0.72 91

Abbreviations: CHD, coronary heart disease; CVD, cardiovascular disease; HF, heart failure; HRQoL, health‐related quality of life; T2D, type 2 diabetes